Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-19-000861
Filing Date
2019-11-25
Accepted
2019-11-25 16:33:44
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss158276_sc13d.htm SC 13D 87312
2 JOINT FILING AGREEMENT ss158276_ex9901.htm EX-99.1 5149
  Complete submission text file 0000947871-19-000861.txt   93977
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Subject) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91207 | Film No.: 191246583
SIC: 3841 Surgical & Medical Instruments & Apparatus